"Aza Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic chemicals where carbon atoms have been replaced by nitrogen atoms.
| Descriptor ID |
D001372
|
| MeSH Number(s) |
D02.145
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aza Compounds".
Below are MeSH descriptors whose meaning is more specific than "Aza Compounds".
This graph shows the total number of publications written about "Aza Compounds" by people in this website by year, and whether "Aza Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2006 | 3 | 0 | 3 |
| 2009 | 2 | 0 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aza Compounds" by people in Profiles.
-
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616. J Am Coll Cardiol. 2023 04 25; 81(16):1553-1564.
-
Fungal keratitis responsive to moxifloxacin monotherapy. Cornea. 2012 Oct; 31(10):1206-9.
-
Diastereoselective control of intramolecular aza-Michael reactions using achiral catalysts. Org Lett. 2011 Oct 21; 13(20):5556-9.
-
Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas. J Clin Microbiol. 2011 Aug; 49(8):2942-5.
-
Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design. J Antimicrob Chemother. 2011 May; 66(5):1079-86.
-
Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model. J Antimicrob Chemother. 2009 Sep; 64(3):556-62.
-
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009 Aug 01; 180(3):273-80.
-
Central venous catheter-related Streptomyces septic thrombosis. Infect Control Hosp Epidemiol. 2007 May; 28(5):599-601.
-
Vitreal penetration of oral and topical moxifloxacin in humans. Am J Ophthalmol. 2007 Feb; 143(2):338-40.
-
Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. Invest Ophthalmol Vis Sci. 2006 Apr; 47(4):1606-11.